Search
for
Sort by
Research 61–90 of 217
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- The evolution of primary multimodality treatment in resectable breast cancer
- Alopecia
- A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro
- Effect of a medicinal and edible decoction YH0618 on chemotherapy-induced dermatologic toxicity: a randomized controlled trial
- Prevention of chemotherapy-induced alopecia in rodent models
- Permanent chemotherapy-induced alopecia after hematopoietic stem cell transplantation treated with low-dose oral minoxidil
- Cytoprotective role of human dental pulp stem cell-conditioned medium in chemotherapy-induced alopecia
- Ayurveda-based Botanicals as Therapeutic Adjuvants in Paclitaxel-induced Myelosuppression
- "A Natural Product that Accelerates Hair Growth in Women with Chemotherapy-Induced Alopecia"
- Treatment of Chemotherapy Induced Alopecia
- Optimizing Scalp Cooling: (Ultra)Structural Follicular Characteristic and Restorative Advances
- Advancements in non-laser energy-based devices in trichology: A comprehensive review
- Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study
- Copper−Doxorubicin as a Nanoparticle Cargo Retains Efficacy with Minimal Toxicity
- Chinese Herbal Medicine for Reducing Chemotherapy-Associated Side-Effects in Breast Cancer Patients: A Systematic Review and Meta-Analysis
- Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors
- The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial
- A Nonrandomized Clinical Trial Investigating Keratinocyte Growth Factor‐Hair Serum for the Prevention of Chemotherapy‐Induced Alopecia
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Efficacy of bimatoprost in treating chemotherapy-induced milphosis: A comprehensive review of randomized controlled trials
- 9-cis-Retinoic Acid Capsules in the Treatment of AIDS-Related Kaposi Sarcoma
- Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis
- Associations Between GLP‐1 Receptor Agonists and Alopecia: A Multi‐Centre Retrospective Analysis and Public Interest Trends
- Chitosan Nanoparticles for Topical Drug Delivery in Chemotherapy-Induced Alopecia: A Comparative Study of Five Repurposed Pharmacological Agents
- Qualitative and Quantitative Assessment of Taste and Smell Changes in Patients Undergoing Chemotherapy for Breast Cancer or Gynecologic Malignancies
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
- Scalp hypothermia as a preventative measure for chemotherapy‐induced alopecia: a review of controlled clinical trials